Labrador, Baby Girl .
HRN: 24-76-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2025
CEFUROXIME 750MG (VIAL)
10/04/2025
10/11/2025
IVT
270mg
Q8
URTI; T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes